← back to search

Mingzhou Guo

Huazhong University of Science and Technology · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Cancer research and Angiogenesis, with related work in Downregulation and upregulation, Catenin, Wnt signaling pathway. Notable publications include 'RACK1 Suppresses Gastric Tumorigenesis by Stabilizing the β-Catenin Destruction Complex', 'Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors', and 'Methylation‐mediated repression of micro RNA 129‐2 enhances oncogenic SOX 4 expression in HCC'.
h-index
citations
362
works
7
NIH funding
primary concept
email

Recent publications

Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway
Journal of Experimental & Clinical Cancer Research 2023cited by 22position: middledoi
Additional file 1 of Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway
Open MIND 2023cited by 0position: middledoi
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
Nature Cancer 2021cited by 78position: middledoi
Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma
Journal of Molecular Medicine 2017cited by 25position: middledoi
Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation
Antioxidants and Redox Signaling 2016cited by 65position: middledoi
RACK1 Suppresses Gastric Tumorigenesis by Stabilizing the β-Catenin Destruction Complex
Gastroenterology 2012cited by 105position: middledoi
Methylation‐mediated repression of micro<scp>RNA</scp> 129‐2 enhances oncogenic <scp>SOX</scp>4 expression in <scp>HCC</scp>
Liver International 2012cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jing Xu · South China University of Technology2 papers (2023–2023)Zitong Zhao · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2023–2023)Liying Ma · Ministry of Education2 papers (2023–2023)Ji Ming Wang · University of Colorado Denver2 papers (2016–2017)Hongyu Yuan · Central South University2 papers (2023–2023)Yongmei Song · Hebei Medical University2 papers (2023–2023)Weihong Zhao · Chinese PLA General Hospital2 papers (2023–2023)Shuye Lin · Center for Cancer Research2 papers (2016–2017) · 2 papers (2016–2017)Jiaqiang Huang · Guangdong University of Technology2 papers (2016–2017)Hui Zhuang · Shandong University1 papers (2012–2012)Xiaoyue Wang · Tongji University1 papers (2017–2017)Yong Liu · Fuyang Normal University1 papers (2012–2012)Xiaolei Zhang · Harbin Medical University1 papers (2012–2012)Ling Zhang · Hebei Medical University1 papers (2012–2012)Ting Zhang · Indiana University School of Medicine1 papers (2012–2012)Xiang Du · Fudan University1 papers (2012–2012)Ruiping Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2023–2023)Jing Gao · Fudan University1 papers (2016–2016)Yongfeng Wang · Guangdong University of Technology1 papers (2012–2012)